+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluticasone Propionate "

From
From
From
Advair - Product Thumbnail Image

Advair

  • Report
  • July 2018
  • 37 Pages
  • Global
From
Drug Analysis: Advair - Product Thumbnail Image

Drug Analysis: Advair

  • Drug Pipelines
  • February 2018
  • 35 Pages
  • Global
From
Drug Analysis: Flutiform - Product Thumbnail Image

Drug Analysis: Flutiform

  • Drug Pipelines
  • February 2018
  • 17 Pages
  • Global
From
Drug Overview: Flutiform - Product Thumbnail Image

Drug Overview: Flutiform

  • Report
  • February 2018
  • 17 Pages
  • Global
From
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 90 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Fluticasone Propionate is a corticosteroid used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. It is available in both inhaler and nasal spray forms, and is often prescribed in combination with other medications. Fluticasone Propionate is a widely used medication in the respiratory drug market, and is often prescribed as a first-line treatment for asthma and COPD. The Fluticasone Propionate market is highly competitive, with many pharmaceutical companies offering their own branded versions of the drug. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. Other companies such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals also offer generic versions of the drug. Show Less Read more